Virtual Patient: Rhinitis and Asthma in a Pregnant Patient
This case simulation involves a female patient who has struggled with allergy and asthma symptoms, particularly in the spring and fall, for quite some time. Shortly after finding a comprehensive treatment regimen that relieves her symptoms, she becomes pregnant, and must explore with her care provider how the treatment will change during her pregnancy. FDA guidelines, practice parameters, and pertinent research will be discussed.
Making IT Count is funded through an educational grant from Merck & Co., Inc.
- Allied Health providers
Upon completion of this simulation activity, participants should be able to:
- Elect the best long-term treatment for this patient’s allergy and asthma symptoms
- Determine appropriate treatment options for this pregnant patient according to published guidelines
- Treat a pregnant patient’s adverse reaction to immunotherapy treatment
Peter Socrates Creticos, MD FAAAAI
Creticos Research Group, Crownsville, MD
Relevant relationships: Circassia, Greer: Consulting;
Merck-Schering-Plough: Research funding
Tolly Goldberg Epstein, MD FAAAAI
University of Cincinnati, Cincinnati, OH
Allergy Partners of Central Indiana, Indianapolis, IN
Relevant Relationships: Merck: Consultant
Anne E. Borgmeyer, RN CPNP AE-C
St. Louis Children's Hospital, St. Louis, MO
Relevant relationships: None
William R. McKenna, MD FAAAAI
McKenna Allergy & Asthma Center, San Antonio, TX
Relevant relationships: None
AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:
- Employment. Name of employer and job title.
- Financial interests. All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
- Research interests. All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
- Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
- Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
- Gifts. All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
- Other interests. All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.
The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.
Original release date: May 17, 2016. Reviewed by Tolly Epstein, MD FAAAAI on June 5, 2018. Valid for credit through May 16, 2020.
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE Designation Statement
The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 0.25 Contact Hours.
Medium and Method of Physician Participation
Follow these steps to complete the activity:
- Register for the activity.
- Review the CME Info and Disclosure information.
- Complete all required components.
- Complete the Commitment to Change form.
- Complete the activity evaluation.
- Claim your credits. Enter only the number of credits earned based on your participation in the activity.
- Print or save your certificate.
To verify your participation in live educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at email@example.com.
- 0.25 AttendanceAttendance credit.
- 0.25 CECE credit.
- 0.25 CMECME credit.
One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari. Internet Explorer is not recommended.
Pop-ups must be enabled in order to access all course content. The course will pop-up in a new window.
When you finish the course, you must close the pop-up in order to move forward.